Healthcare / Medical DistributionShenzhen
$5.70
-0.13 (-2.23%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 13%
FCF escenarios
weak_data · normalized FCF $264.1M · quality 23.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
34/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$9.9B
P/E
22.8x
↑EV/EBITDA
13.9x
↑ROE
3.4%
↑Gross Margin
7.2%
↓Debt/Equity
2.00
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+6.7%
FCF CAGR
+194.8%
FCF margin
0.6%
FCF / Net income
1.18x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $82.45B · net income $386.7M · FCF $455.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $82.45B | $82.45B | $80.56B | $78.40B | $67.83B |
| Net Income | $386.7M | $386.7M | $283.0M | $624.6M | $952.3M |
| EBITDA | $1.91B | $1.91B | $2.16B | $2.71B | $3.00B |
| EPS | 0.22 | 0.22 | 0.16 | 0.36 | 0.55 |
| Gross Margin | 7.2% | 7.2% | 7.4% | 8.0% | 8.6% |
| Operating Margin | 2.3% | 2.3% | 2.3% | 3.1% | 3.5% |
| Net Margin | 0.5% | 0.5% | 0.4% | 0.8% | 1.4% |
| Balance Sheet | |||||
| Debt/Equity | 2.00 | 2.00 | 2.07 | 1.80 | 2.08 |
| Current Ratio | 1.20 | 1.20 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $455.1M | $455.1M | $-437.3M | $264.1M | $17.8M |
| Returns | |||||
| ROE | 3.4% | 3.4% | 2.5% | 5.6% | 8.9% |
| Valuation | |||||
| P/E | 22.80 | 22.80 | 31.37 | 13.81 | 9.38 |
| EV/EBITDA | 13.86 | 13.86 | 10.61 | 7.27 | 7.88 |
| P/B | 0.87 | 0.87 | 0.78 | 0.77 | 0.84 |
| Growth & Yield | |||||
| Revenue Growth | 2.3% | 2.3% | 2.8% | 15.6% | — |
| EPS Growth | 37.5% | 37.5% | -55.6% | -34.5% | — |
| Dividend Yield | 1.1% | 1.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
32.0%
EPS terminal req.
$0.51
Spread vs growth
5.5%
5Y implied EPS CAGR
22.7%
EPS terminal req.
$0.61
Spread vs growth
14.8%
10Y implied EPS CAGR
16.2%
EPS terminal req.
$0.99
Spread vs growth
21.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+15.5%
Start / end P/E
31.1x → 25.9x
EPS bridge
0.16 → 0.22
Residual
-6.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.